Lv2
150 积分 2024-08-12 加入
Metabolomic comparative study in patients with liver cirrhosis and hepatocellular carcinoma related to hepatitis B virus infection
16天前
已完结
Transparency in the Reporting of Artificial Intelligence – The TITAN Guideline
2个月前
已完结
Updated results of a phase 1b/2 study of surufatinib plus camrelizumab, nab-paclitaxel and S-1 (NASCA) as first-line therapy for metastatic pancreatic adenocarcinoma (mPDAC)
4个月前
已完结
Tumor Necrosis Is an Indicator of Poor Prognosis Among Hepatoma Patients Undergoing Resection
6个月前
已完结
皖公网安备34019202002308
